Rock Springs Capital
Baltimore, United States
154
109M
122
14.00
8
0.21
73
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Baltimore. The company was established in North America in United States.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular fund investment industries, there are Medical, Health Diagnostics. Among the most popular portfolio startups of the fund, we may highlight AveXis, Spark Therapeutics, Audentes Therapeutics. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Opposing the other organizations, this Rock Springs Capital works on 49 percentage points more the average amount of lead investments. The higher amount of exits for fund were in 2015. Deals in the range of 50 - 100 millions dollars are the general things for fund. The typical startup value when the investment from Rock Springs Capital is 500 millions - 1 billion dollars. The real fund results show that this VC is 16 percentage points less often commits exit comparing to other companies. The fund is generally included in 7-12 deals every year. The top activity for fund was in 2015. Despite it in 2019 the fund had an activity.
Besides them, we counted 1 critical employee of this fund in our database.
The typical case for the fund is to invest in rounds with 8-9 participants. Despite the Rock Springs Capital, startups are often financed by OrbiMed, Sofinnova Investments, Bay City Capital. The meaningful sponsors for the fund in investment in the same round are Deerfield, Wellington Management, Vivo Capital. In the next rounds fund is usually obtained by New Enterprise Associates, Omega Funds, CARB-X.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 154
- Lead investments
- 8
- Exits
- 73
- Rounds per year
- 14.00
- Follow on index
- 0.21
- Investments by industry
- Biotechnology (137)
- Health Care (82)
- Medical (67)
- Therapeutics (57)
- Pharmaceutical (48) Show 33 more
- Investments by region
-
- United States (127)
- United Kingdom (9)
- China (5)
- Canada (3)
- Singapore (2) Show 7 more
- Peak activity year
- 2021
- Number of Unicorns
- 8
- Number of Decacorns
- 8
- Number of Minotaurs
- 15
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Avg. valuation at time of investment
- 223M
- Group Appearance index
- 1.00
- Avg. company exit year
- 9
- Avg. multiplicator
- 2.85
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Immuneering | 05 Jan 2021 | Biotechnology, Medical, Pharmaceutical | Early Stage Venture | 62M | United States, Massachusetts, Cambridge |
Treeline Biosciences | 11 Oct 2022 | Biotechnology, Health Care, Life Science | Early Stage Venture | 261M | United States, Connecticut, Stamford |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.